PACB
Price:
$1.58
Market Cap:
$430.60M
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and s...[Read more]
Industry
Medical - Devices
IPO Date
2010-10-27
Stock Exchange
NASDAQ
Ticker
PACB
According to Pacific Biosciences of California, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.05. This represents a change of -78.53% compared to the average of -4.89 of the last 4 quarters.
The mean historical PE Ratio of Pacific Biosciences of California, Inc. over the last ten years is 4.82. The current -1.05 PE Ratio has changed -2276.73% with respect to the historical average. Over the past ten years (40 quarters), PACB's PE Ratio was at its highest in in the March 2020 quarter at 93.02. The PE Ratio was at its lowest in in the December 2019 quarter at -2161.21.
Average
4.82
Median
-8.23
Minimum
-31.32
Maximum
152.59
Discovering the peaks and valleys of Pacific Biosciences of California, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 275.07%
Maximum Annual PE Ratio = 152.59
Minimum Annual Increase = -1614.60%
Minimum Annual PE Ratio = -31.32
Year | PE Ratio | Change |
---|---|---|
2023 | -8.11 | 31.18% |
2022 | -6.18 | -73.10% |
2021 | -22.99 | -115.07% |
2020 | 152.59 | -1614.60% |
2019 | -10.07 | 3.47% |
2018 | -9.74 | 221.73% |
2017 | -3.03 | -33.56% |
2016 | -4.55 | -85.46% |
2015 | -31.32 | 275.07% |
2014 | -8.35 | 101.67% |
The current PE Ratio of Pacific Biosciences of California, Inc. (PACB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-12.43
5-year avg
21.05
10-year avg
4.82
Pacific Biosciences of California, Inc.’s PE Ratio is less than Invitae Corporation (-0.00), greater than Twist Bioscience Corporation (-9.69), greater than Intellia Therapeutics, Inc. (-3.76), greater than CRISPR Therapeutics AG (-14.26), greater than Editas Medicine, Inc. (-1.53),
Company | PE Ratio | Market cap |
---|---|---|
-0.00 | $5.44M | |
-9.69 | $2.15B | |
-3.76 | $2.00B | |
-14.26 | $3.80B | |
-1.53 | $296.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacific Biosciences of California, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pacific Biosciences of California, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pacific Biosciences of California, Inc.'s PE Ratio?
How is the PE Ratio calculated for Pacific Biosciences of California, Inc. (PACB)?
What is the highest PE Ratio for Pacific Biosciences of California, Inc. (PACB)?
What is the 3-year average PE Ratio for Pacific Biosciences of California, Inc. (PACB)?
What is the 5-year average PE Ratio for Pacific Biosciences of California, Inc. (PACB)?
How does the current PE Ratio for Pacific Biosciences of California, Inc. (PACB) compare to its historical average?